| Literature DB >> 31024499 |
Raquel Ferrer-Espada1,2, Xiaojing Liu1,2, Xueping Sharon Goh1,2, Tianhong Dai1,2.
Abstract
Polymicrobial biofilms, in which mixed microbial species are present, play a significant role in persistent infections. Furthermore, polymicrobial biofilms promote antibiotic resistance by allowing interspecies transfer of antibiotic resistance genes. In the present study, we investigated the effectiveness of antimicrobial blue light (aBL; 405 nm), an innovative non-antibiotic approach, for the inactivation of polymicrobial biofilms. Dual-species biofilms with Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA) as well as with P. aeruginosa and Candida albicans were reproducibly grown in 96-well microtiter plates or in the CDC biofilm reactor for 24 or 48 h. The effectiveness of aBL inactivation of polymicrobial biofilms was determined through colony forming assay and compared with that of monomicrobial biofilms of each species. aBL-induced morphological changes of biofilms were analyzed with confocal laser scanning microscopy (CLSM) and scanning electron microscopy (SEM). For 24-h old monomicrobial biofilms formed in 96-well microtiter plates, 6.30-log10 CFU inactivation of P. aeruginosa, 2.33-log10 CFU inactivation of C. albicans and 3.48-log10 CFU inactivation of MRSA were observed after an aBL exposure of 500 J/cm2. Under the same aBL exposure, 6.34-log10 CFU inactivation of P. aeruginosa and 3.11-log10 CFU inactivation of C. albicans were observed, respectively, in dual-species biofilms. In addition, 2.37- and 3.40-log10 CFU inactivation were obtained in MRSA and P. aeruginosa, dual-species biofilms. The same aBL treatment of the biofilms developed in the CDC-biofilm reactor for 48 h significantly decreased the viability of P. aeruginosa monomicrobial and polymicrobial biofilm when cocultured with MRSA (3.70- and 3.56-log10 CFU inactivation, respectively). 2.58-log10 CFU inactivation and 0.86-log10 CFU inactivation was detected in MRSA monomicrobial and polymicrobial biofilm when cocultured with P. aeruginosa. These findings were further supported by the CLSM and SEM experiments. Phototoxicity studies revealed a no statistically significant loss of viability in human keratinocytes after an exposure to 216 J/cm2 and a statistically significant loss of viability after 500 J/cm2. aBL is potentially an alternative treatment against polymicrobial biofilm-related infections. Future studies will aim to improve the efficacy of aBL and to investigate aBL treatment of polymicrobial biofilm-related infections in vivo.Entities:
Keywords: CDC biofilm reactor; Candida albicans; Pseudomonas aeruginosa; Staphylococcus aureus; antimicrobial blue light; biofilm; endogenous photosensitizer; polymicrobial
Year: 2019 PMID: 31024499 PMCID: PMC6467927 DOI: 10.3389/fmicb.2019.00721
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Effectiveness of antimicrobial blue light (405 nm) inactivation of biofilms grown in 96-well microtiter plates after 24 h of incubation.
| Biofilm type | Strain | Irradiance | Irradiation | Radiant | Biofilm cell density | SE | Survival bacterial counts | SE | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Monomicrobial | CEC 749 | 60.0 | 60 | 216 | 7.58 | 0.20 | -0.35 | ns | 0.14 | |
| 92.6 | 90 | 500 | 7.94 | 0.07 | -2.33 | ∗∗ | 0.18 | |||
| MRSA | USA300 | 60.0 | 60 | 216 | 8.70 | 0.11 | -1.20 | ns | 0.20 | |
| 92.6 | 90 | 500 | 8.54 | 0.27 | -3.48 | ∗∗∗ | 0.39 | |||
| IQ0046 | 60.0 | 60 | 216 | 8.77 | 0.33 | -6.55 | ∗∗∗ | 0.45 | ||
| 92.6 | 90 | 500 | 8.97 | 0.86 | -6.30 | ∗∗∗ | 0.36 | |||
| Polymicrobial | CEC 749 | 60.0 | 60 | 216 | 6.99 | 0.08 | -2.46 | ∗∗ | 0.84 | |
| 92.6 | 90 | 500 | 6.96 | 0.09 | -3.11 | ∗∗∗ | 0.43 | |||
| IQ0046 | 60.0 | 60 | 216 | 9.98 | 0.17 | -5.67 | ∗∗∗ | 0.38 | ||
| 92.6 | 90 | 500 | 8.86 | 0.14 | -6.34 | ∗∗∗ | 0.20 | |||
| Polymicrobial | MRSA | USA 300 | 60.0 | 60 | 216 | 8.23 | 0.09 | -1.42 | ns | 0.24 |
| 92.6 | 90 | 500 | 8.96 | 0.14 | -2.37 | ∗∗ | 0.23 | |||
| IQ0046 | 60.0 | 60 | 216 | 8.05 | 0.08 | -3.94 | ∗∗∗ | 0.09 | ||
| 92.6 | 90 | 500 | 8.28 | 0.03 | -3.40 | ∗∗∗ | 0.34 | |||
Effectiveness of antimicrobial blue light (405 nm) inactivation of biofilms grown in 96-well microtiter plates after 48 h of incubation.
| Biofilm type | Strain | Irradiance | Irradiation | Radiant | Biofilm cell density | SE | Survival bacterial counts | SE | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Monomicrobial | CEC 749 | 60.0 | 60 | 216 | 8.41 | 0.06 | -0.25 | ns | 0.26 | |
| 92.6 | 90 | 500 | 8.51 | 0.09 | -2.11 | ∗∗∗ | 0.09 | |||
| MRSA | USA300 | 60.0 | 60 | 216 | 8.77 | 0.13 | -1.62 | ∗ | 0.13 | |
| 92.6 | 90 | 500 | 9.97 | 0.37 | -2.35 | ∗∗∗ | 0.23 | |||
| IQ0046 | 60.0 | 60 | 216 | 9.34 | 0.23 | -3.67 | ∗∗∗ | 0.73 | ||
| 92.6 | 90 | 500 | 8.88 | 0.16 | -6.88 | ∗∗∗ | 0.16 | |||
| Polymicrobial | CEC 749 | 60.0 | 60 | 216 | 6.84 | 0.30 | -2.96 | ∗∗∗ | 0.40 | |
| 92.6 | 90 | 500 | 6.02 | 0.28 | -3.41 | ∗∗∗ | 0.21 | |||
| IQ0046 | 60.0 | 60 | 216 | 9.45 | 0.18 | -5.48 | ∗∗∗ | 0.17 | ||
| 92.6 | 90 | 500 | 9.41 | 0.29 | -7.41 | ∗∗∗ | 0.29 | |||
| Polymicrobial | MRSA | USA 300 | 60.0 | 60 | 216 | 8.50 | 0.24 | -2.44 | ∗∗∗ | 0.39 |
| 92.6 | 90 | 500 | 8.44 | 0.09 | -2.61 | ∗∗∗ | 0.08 | |||
| IQ0046 | 60.0 | 60 | 216 | 8.80 | 0.12 | -4.19 | ∗∗∗ | 0.10 | ||
| 92.6 | 90 | 500 | 8.15 | 0.08 | -3.67 | ∗∗∗ | 0.24 | |||
Antimicrobial blue light (405 nm) inactivation of biofilms grown in the CDC biofilm reactor after 48 h of incubation.
| Biofilm type | Strain | Irradiance | Irradiation | Radiant | Biofilm cell density | SE | Survival bacterial counts | SE | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Monomicrobial | CEC 749 | 60.0 | 60 | 216 | 7.25 | 0.08 | -0.14 | ns | 0.26 | |
| 92.6 | 90 | 500 | 7.48 | 0.12 | -1.04 | ns | 0.25 | |||
| MRSA | USA300 | 60.0 | 60 | 216 | 6.83 | 0.10 | -2.05 | ns | 0.33 | |
| 92.6 | 90 | 500 | 6.83 | 0.10 | -2.58 | ns | 0.30 | |||
| IQ0046 | 60.0 | 60 | 216 | 9.52 | 0.92 | -1.48 | ns | 0.14 | ||
| 92.6 | 90 | 500 | 8.94 | 0.38 | -3.70 | ∗∗ | 0.95 | |||
| Polymicrobial | CEC 749 | 92.6 | 90 | 500 | 5.83 | 0.15 | -1.71 | ns | 0.16 | |
| IQ0046 | 92.6 | 90 | 500 | 8.07 | 0.12 | -2.58 | ns | 0.45 | ||
| Polymicrobial | MRSA | USA300 | 60.0 | 60 | 216 | 7.44 | 0.20 | -0.80 | ns | 0.57 |
| 92.6 | 90 | 500 | 7.44 | 0.20 | -0.86 | ns | 0.41 | |||
| IQ0046 | 60.0 | 60 | 216 | 7.52 | 0.23 | -1.80 | ns | 0.28 | ||
| 92.6 | 90 | 500 | 7.52 | 0.23 | -3.56 | ∗∗ | 1.07 | |||
FIGURE 1Confocal laser microscope images showing the cytotoxic activity of aBL in P. aeruginosa IQ0046, MRSA USA300 and C. albicans CEC 749 mono and polymicrobial biofilms. Scale bars represent 10 or 100 μm. NT, no treatment; aBL, biofilm treated with 405-nm aBL (92.6 mW/cm2, 500 J/cm2). In the polymicrobial biofilms, ∗ indicate C. albicans CEC 749, solid white arrows indicate P. aeruginosa IQ0046 and dashed line arrows indicate MRSA USA300.
FIGURE 2Scanning electron microscope images showing the cytotoxic activity of aBL at 405 nm in P. aeruginosa IQ0046 and C. albicans CEC 749 monomicrobial and polymicrobial biofilms after an aBL exposure of 500 J/cm2 (92.6 mW/cm2 and 90 min). Scale bars represent 500, 20, or 2 μm.
FIGURE 3Scanning electron microscope images showing the bactericidal activity of aBL at 405 nm in P. aeruginosa IQ0046 and MRSA USA300 monomicrobial and dual-species microbial biofilms after an aBL exposure of 500 J/cm2 (92.6 mW/cm2 and 90 min). Scale bars represent 20 or 2 μm.
FIGURE 4Cytotoxicity of 405-nm aBL to normal human HaCaT cells after an exposure of 216 J/cm2 (60 mW/cm2, 60 min) or 500 J/cm2 (92.6 mW/cm2, 90 min). 0 vs 216 J/cm2 (P = 0.4016) and 0 vs 500 J/cm2 (P = 0.0011). Bars are the SE. ∗∗P < 0.01.